Shauna Farr-Jones | UCSF Profiles

Shauna Farr-Jones, PhD

Title	Academic Coordinator III
Institution	University of California San Francisco
Department	Anesthesia
Address	1001 Potrero Ave San Francisco CA 94110
vCard	Download vCard

Research

Research Activities and Funding

Resource for Biocomputing, Visualization, and Informatics
NIH/NCRR P41RR001081Jun 1, 1976 - Sep 14, 2012
Role: Co-Investigator

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.

List All | Timeline

Li M, Lee D, Obi CR, Freeberg JK, Farr-Jones S, Tomic MT. An ambient temperature-stable antitoxin of nine co-formulated antibodies for botulism caused by serotypes A, B and E. PLoS One. 2018; 13(5):e0197011. PMID: 29746518.

View in: PubMed
Wijesuriya SD, Pongo E, Tomic M, Zhang F, Garcia-Rodriquez C, Conrad F, Farr-Jones S, Marks JD, Horwitz AH. Antibody engineering to improve manufacturability. Protein Expr Purif. 2018 Apr 12. PMID: 29655788.

View in: PubMed
Garcia-Rodriguez C, Razai A, Geren IN, Lou J, Conrad F, Wen WH, Farr-Jones S, Smith TJ, Brown JL, Skerry JC, Smith LA, Marks JD. A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes. Toxins (Basel). 2018 Mar 01; 10(3). PMID: 29494481.

View in: PubMed
Lou J, Wen W, Conrad F, Meng Q, Dong J, Sun Z, Garcia-Rodriguez C, Farr-Jones S, Cheng LW, Henderson TD, Brown JL, Smith TJ, Smith LA, Cormier A, Marks JD. A Single Tri-Epitopic Antibody Virtually Recapitulates the Potency of a Combination of Three Monoclonal Antibodies in Neutralization of Botulinum Neurotoxin Serotype A. Toxins (Basel). 2018 Feb 15; 10(2). PMID: 29462889.

View in: PubMed
Zhou Y, Zou H, Yau C, Zhao L, Hall SC, Drummond DC, Farr-Jones S, Park JW, Benz CC, Marks JD. Discovery of internalizing antibodies to basal breast cancer cells. Protein Eng Des Sel. 2018 Jan 01; 31(1):17-28. PMID: 29301020.

View in: PubMed
Fox S, Farr-Jones S, Sopchak L, Boggs A, Nicely HW, Khoury R, Biros M. High-throughput screening: update on practices and success. J Biomol Screen. 2006 Oct; 11(7):864-9. PMID: 16973922.

View in: PubMed
Fox S, Farr-Jones S, Sopchak L, Boggs A, Comley J. High-throughput screening: searching for higher productivity. J Biomol Screen. 2004 Jun; 9(4):354-8. PMID: 15191652.

View in: PubMed
Fox S, Wang H, Sopchak L, Farr-Jones S. High throughput screening 2002: moving toward increased success rates. J Biomol Screen. 2002 Aug; 7(4):313-6. PMID: 12230884.

View in: PubMed
Farr-Jones S. Business and science of proteomics--third annual event. Next-generation technologies for high-throughput proteomics. IDrugs. 2001 Nov; 4(11):1235-6. PMID: 15942822.

View in: PubMed
Avizonis D, Farr-Jones S. The Internet for nuclear magnetic resonance spectroscopists. Methods Enzymol. 2001; 338:247-57. PMID: 11460551.

View in: PubMed
Farr-Jones S. Chemokine antagonists as anti-inflammatory and antiviral agents II. IDrugs. 2000 Jun; 3(6):584-5. PMID: 16096911.

View in: PubMed
Liu H, Farr-Jones S, Ulyanov NB, Llinas M, Marqusee S, Groth D, Cohen FE, Prusiner SB, James TL. Solution structure of Syrian hamster prion protein rPrP(90-231). Biochemistry. 1999 Apr 27; 38(17):5362-77. PMID: 10220323.

View in: PubMed
Fox S, Farr-Jones S, Yund MA. High Throughput Screening for Drug Discovery: Continually Transitioning into New Technology. J Biomol Screen. 1999; 4(4):183-186. PMID: 10838437.

View in: PubMed
Armand P, Kirshenbaum K, Goldsmith RA, Farr-Jones S, Barron AE, Truong KT, Dill KA, Mierke DF, Cohen FE, Zuckermann RN, Bradley EK. NMR determination of the major solution conformation of a peptoid pentamer with chiral side chains. Proc Natl Acad Sci U S A. 1998 Apr 14; 95(8):4309-14. PMID: 9539733; PMCID: PMC22485.

View in: PubMed, PubMed Central
James TL, Liu H, Ulyanov NB, Farr-Jones S, Zhang H, Donne DG, Kaneko K, Groth D, Mehlhorn I, Prusiner SB, Cohen FE. Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc Natl Acad Sci U S A. 1997 Sep 16; 94(19):10086-91. PMID: 9294167; PMCID: PMC23313.

View in: PubMed, PubMed Central
Farr-Jones S, Miljanich GP, Nadasdi L, Ramachandran J, Basus VJ. Solution structure of omega-conotoxin MVIIC, a high affinity ligand of P-type calcium channels, using 1H NMR spectroscopy and complete relaxation matrix analysis. J Mol Biol. 1995 Apr 21; 248(1):106-24. PMID: 7731037.

View in: PubMed
Hedstrom L, Farr-Jones S, Kettner CA, Rutter WJ. Converting trypsin to chymotrypsin: ground-state binding does not determine substrate specificity. Biochemistry. 1994 Jul 26; 33(29):8764-9. PMID: 8038166.

View in: PubMed
Farr-Jones S, Smith SO, Kettner CA, Griffin RG, Bachovchin WW. Crystal versus solution structure of enzymes: NMR spectroscopy of a peptide boronic acid-serine protease complex in the crystalline state. Proc Natl Acad Sci U S A. 1989 Sep; 86(18):6922-4. PMID: 2780549; PMCID: PMC297962.

View in: PubMed, PubMed Central
Smith SO, Farr-Jones S, Griffin RG, Bachovchin WW. Crystal versus solution structures of enzymes: NMR spectroscopy of a crystalline serine protease. Science. 1989 May 26; 244(4907):961-4. PMID: 2499045.

View in: PubMed
Bachovchin WW, Wong WY, Farr-Jones S, Shenvi AB, Kettner CA. Nitrogen-15 NMR spectroscopy of the catalytic-triad histidine of a serine protease in peptide boronic acid inhibitor complexes. Biochemistry. 1988 Oct 04; 27(20):7689-97. PMID: 3207700.

View in: PubMed